Studies of complex Ph translocations in cases with chronic myelogenous leukemia and one with acute lymphoblastic leukemia

被引:9
作者
Costa, D
Carrió, A
Madrigal, I
Arias, A
Valera, A
Colomer, D
Aguilar, JL
Teixido, M
Camós, M
Cervantes, F
Campo, E
机构
[1] Hosp Clin Barcelona, Hematopathol Unit, Barcelona 08036, Catalonia, Spain
[2] Hosp Clin Barcelona, Genet Serv, Barcelona 08036, Catalonia, Spain
[3] Hosp Clin Barcelona, Dept Hematol, Barcelona 08036, Catalonia, Spain
[4] Hosp Arnau Vilanova, Lleida, Catalonia, Spain
关键词
D O I
10.1016/j.cancergencyto.2005.08.024
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The BCR/ABL gene fusion, the hallmark of chronic myelogenous leukemia (CML) is generated in 2-10% of patients by a variant Ph translocation involving 9q34, 22q11.2, and one or more additional genomic regions. The objective of this study was the characterization by conventional and molecular cytogenetics of complex variant Ph translocations present at diagnosis. FISH studies were performed in 7 cases using the LSI BCR/ABL ES probe allowing the detection of the fusion BCR/ABL gene on the Ph chromosome in all of them and 9q34 deletions in 2 cases. Three cryptic complex rearrangements were detected by FISH studies. The third and the fourth chromosome regions involved in the 8 complex variant translocations were: 1q21, 1p36, 5q31, 11q13, 121q13, 12p13, and 20q12. In conclusion, FISH studies have been useful in the detection of the BCR/ABL rearrangements and 9q34 deletions, and to identify complex rearrangements that differ from the ones previously established by conventional cytogenetics. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:89 / 93
页数:5
相关论文
共 17 条
[1]   Interphase fluorescence in situ hybridization studies for the detection of 9q34 deletions in chronic myelogenous leukemia: a practical approach to clinical diagnosis [J].
Aoun, P ;
Wiggins, M ;
Pickering, D ;
Foran, J ;
Rasheed, H ;
Pavletic, SZ ;
Sanger, W .
CANCER GENETICS AND CYTOGENETICS, 2004, 154 (02) :138-143
[2]   Subgroup of patients with Philadelphia-positive chronic myelogenous leukemia characterized by a deletion of 9q proximal to ABL gene:: expression profiling, resistance to interferon therapy, and poor prognosis [J].
Cohen, N ;
Rozenfeld-Granot, G ;
Hardan, I ;
Brok-Simoni, F ;
Amariglio, N ;
Rechavi, G ;
Trakhtenbrot, L .
CANCER GENETICS AND CYTOGENETICS, 2001, 128 (02) :114-119
[3]   COMPLEX CHROMOSOMAL TRANSLOCATIONS IN THE PHILADELPHIA-CHROMOSOME LEUKEMIAS - SERIAL TRANSLOCATIONS OR A CONCERTED GENOMIC REARRANGEMENT [J].
FITZGERALD, PH ;
MORRIS, CM .
CANCER GENETICS AND CYTOGENETICS, 1991, 57 (02) :143-151
[4]   Imatinib improves but may not fully reverse the poor prognosis of patients with CML with derivative chromosome 9 deletions [J].
Huntly, BJP ;
Guilhot, F ;
Reid, AG ;
Vassiliou, G ;
Hennig, E ;
Franke, C ;
Byrne, J ;
Brizard, A ;
Niederwieser, D ;
Freeman-Edward, J ;
Cuthbert, G ;
Bown, N ;
Clark, RE ;
Nacheva, EP ;
Green, AR ;
Deininger, MWN .
BLOOD, 2003, 102 (06) :2205-2212
[5]   Deletions of the derivative chromosome 9 occur at the time of the Philadelphia translocation and provide a powerful and independent prognostic indicator in chronic myeloid leukemia [J].
Huntly, BJP ;
Reid, AG ;
Bench, AJ ;
Campbell, LJ ;
Telford, N ;
Shepherd, P ;
Szer, J ;
Prince, HM ;
Turner, P ;
Grace, C ;
Nacheva, EP ;
Green, AR .
BLOOD, 2001, 98 (06) :1732-1738
[6]  
JOHANSSON B, 2002, CHRONIC MYELOPROLIFE, P44
[7]  
KODURU PRK, 1993, ONCOGENE, V8, P3239
[8]   Primary chromosomal rearrangements of leukemia are frequently accompanied by extensive submicroscopic deletions and may lead to altered prognosis [J].
Kolomietz, E ;
Al-Maghrabi, J ;
Brennan, S ;
Karaskova, J ;
Minkin, S ;
Lipton, J ;
Squire, JA .
BLOOD, 2001, 97 (11) :3581-3588
[9]  
MITELMAN F, 2005, MITELMANS DATABASE C
[10]  
Mitelman F, 1995, ISCN INT SYSTEM HUMA